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INTRODUCTION 
Preterm neonate should grow similar to the intrauterine growth of 
the normal fetus of the same gestational age postnatally1. But, most 
preterm neonates end up in a growth-restricted state during their hospital 
stay after birth. Currently, postnatal or extra uterine growth failure is a 
problem in the majority of very low birth weight infants2. 
Studies have shown that inadequate nutrition during vital stages of 
development results in decreased number of brain cells and dendritic 
connections, abnormalities in behavioral and cognitive outcomes.  The 
evidence suggests that early nutrition and neurodevelopment is closely 
linked and we can improve outcomes by preventing "nutritional insults" 
during the first weeks after birth2. Introduction of enteral feeding is 
delayed in these babies due to the fear of feed related issues and owing to 
poor nutrition they enter into a catabolic state, which results in growth 
restriction. There is a critical window of opportunity, between birth and 
birth weight gain, when optimal nutrition has its greatest benefit 3. 
The unique immunological factors present in the human milk 
outweigh any issues that can crop due to early feeding in VLBW babies. 
Maternal milk is the ideal diet for these babies. When mother’s own milk 
is not available the next best option is the donor milk, because of the 
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lower incidence of necrotising enterocolitis, septicemia and better feeding 
progression with donor milk when compared to  the use of formula feed. 
International statement 
The AAP statement and WHO &UNICEF joint statement indicated 
that donor breast milk might be a best alternative option for babies whose 
mothers are not able to provide their own milk.   
Synthesized formulas do not provide the non-nutrient components 
of human milk such as secretory IgA, lysozyme, oligosaccharides, 
polyunsaturated fatty acids, and platelet-activating factor (PAF)-
acetylhydrolase.  These non-nutrient components of human milk 
contribute to GI mucosal integrity, function, and boost immunity against 
various GI infections.  
   At present there is no consensus among healthcare professionals on 
feeding practices in VLBW infants. There are wide variations in feeding 
practices regarding the initiation and rate of progression of enteral feeds. 
The heterogencity of feeding practices are individual based rather than 
evidence based.  
In utero a fetus constantly swallows amniotic fluid. The amniotic 
fluid plays an important role in growth and development of GI tract in 
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fetal life. Postnatally, enteral feedings also stimulate the motility of the 
GI tract and various hormonal secretions 4-6. 
In VLBW neonates   the earlier achievement of full enteral feeding 
is very important.  Full enteral feeding results in decreased risk for sepsis, 
liver dysfunction, inadequate growth and reduced mineral accretion 7. 
Early introduction of enteral feeds is advantageous in resource limited 
settings where the availability and usage of TPN is limited and severe 
infection (septicemia, pneumonia) is an important cause of mortality and 
morbidity.  
  Hence it is worthwhile to study about achievement of full enteral 
feeds from day one of life using exclusively human milk.  This trial also 
gives confidence and encouragement for mothers for achieving successful 
lactation and dispels the disbelief among the health care professionals 
regarding various perceived limitations about enteral feeding.  
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REVIEW OF LITERATURE 
Growth in preterm 
Proper early nutrition of VLBW neonates results in an adequate 
growth and avoids late unphysiological catch-up growth 8. Adequate 
parenteral and enteral nutrition is associated with better outcomes for 
these infants 9. The postnatal weight gain of these babies is associated 
with better neurological outcomes at two years.  
The low nutrient intake plays a major role in growth failure 10. The 
early parenteral and enteral nutritional support provided   is very low 
compared to the fetal nutrient transfer. This results in significant protein 
and energy deficits leading to growth restriction of these neonates.  
Feeding in very low birth weight neonates 
Optimal nutrition during the neonatal period is very important. 
Early introduction and rapid achievement of full enteral feeding is a 
priority in the nutritional management of VLBW infants, because it 
reduces the need for parental nutrition, risk of infection and the duration 
of hospital stay. In resource limited settings where it is difficult to 
administer TPN early initiation of   breast feeding is very important.  
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One of the most important goals during the care of VLBW 
neonates is the attainment of full enteral feeds 11. In feeding practices of 
preterm VLBW infants areas of ambiguity, uncertainty and striking 
unevenness are common rather than standardized evidence based 
protocols 11. 
Feeding practices 
The analysis of various reviews finally concluded that trophic 
feeding, early initiation of feeds and rapid feed advancement ensures less 
feed intolerance and lesser time to achieve full enteral feeds. 
Trophic feeding 
Trophic feeding improves gut motility, helps in earlier attainment 
of full enteral feeding and reduces cholestasis 12-14. 
The Cochrane review (2013) of trophic feeding versus enteral 
fasting for VLBW infants including nine trials with 754 infants involving 
few babies of extremely preterm, ELBW and growth restricted concluded 
that there is no significant difference in the time taken to regain birth 
weight and to establish full enteral feeds15. Meta-analyses did not detect 
statistically significant effects on the incidence of NEC and late-onset 
infection. 
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Early introduction of enteral feeding 
Early enteral feeding strategies have the potential to affect 
important outcomes. Hence it is essential to formulate an uniform policy 
on the best available evidence possible. But at present the feeding 
protocols are conflicting across Nations and even within the Neonatal 
units. Initiation of enteral feeding was delayed mostly due to the fear of 
necrotising enterocolitis but evidence for this practice is weak.  
Benefits of early enteral feeding 
Early introduction of enteral feeding is linked with better growth 
and nitrogen balance. It prevents gastro intestinal atrophy, colonisation of 
enteropathogenic organisms, decreases the need for intravenous fluid and 
total parenteral nutrition and improves the mucosal immunity. Animals 
studies have shown that early feeding was associated with improved 
maturation of gut associated immune function 16.  
Newborns babies are lacking in secretory IgA at birth. Maternal 
colostrum contains high concentrations of IgA helps in the development 
of innate immunity in the Payer’s patches of the small intestine.  Human 
milk contains immunoglobulin of which IgA is 90% and remains 
consistently high whereas other immunoglobulin decreases over time 
with lactation 17.  
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  Wang et al 18 did a study among 49 very low birth weight infants to 
evaluate the safety and benefit of starting enteral feeding early without 
parenteral nutrition. The neonates were divided into two groups. Group A 
(1001-1250 gm, mean GA 29 weeks) and Group B (≤1000 gm, mean GA 
27weeks) and received either breast milk or premature formula. Groups A 
babies regained their birth weight at 20 days and group B babies regained 
at 25 days and there was no increase in the risk of NEC with this feeding 
strategy.  
 De Nisi et al 19 did a study in the Centre of Neonatology of Trento, 
over a period of 16 years (1994-2009)   on early enteral exclusive feeding 
(EEEF) using banked human milk followed by mother milk. Among 308 
babies (weight 750-1249 grams and GA > 26 weeks) admitted, 175 
babies (59 %) were clinically stable and started on EEEF and 119 (40 %) 
babies completed EEEF. These babies had 96% survival rate that could 
be due to the higher use of human milk in their unit. 
Late introduction of enteral feeds 
Various  observational studies have shown that delaying the 
initiation of  enteral feeding  about 5– 7 days after birth and increasing 
the volume of enteral feeds slowly  (<24 ml/Kg/ day) is linked with a 
lesser risk of developing necrotizing enterocolitis. 
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Late initiation of feeds leads to villous atrophy, decreased hormone 
and enzyme production and delayed functional maturation of the GI tract 
and results in abnormal microbial colonisation 20. This may ultimately 
lead the gut at risk for NEC 21 and longer duration of hospital stay. All 
these factors leads to prolonged use of parenteral nutrition which results 
in increased risks of late onset sepsis, cholestatic jaundice 22 and vitamin 
and mineral deficiencies. 
Delayed versus Early Introduction of progressive enteral feeds 
Cochrane review 2013 including seven RCTs   with 964 babies 
concluded that there was no difference in the incidence of NEC between 
early (up to 4 days after birth) or late (later than 5-7 days after birth) 
introduction of progressive enteral feeds for preterm, VLBW babies23. 
Sub group analysis of these trials also concluded that there was no 
statistically   significant effect on the risk of NEC even in growth-
restricted infants with abnormal umbilical artery Doppler flow 24. 
Slow versus faster advancement of enteral feed volumes 
The Cochrane review 2013 of five randomised controlled trials 
with 588 infants comparing slow advancement (defined as 15–20 
ml/Kg/day) and faster advancement (30–35 ml/Kg/day) concluded that no 
statistically significant increase in incidence of NEC among both the 
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groups25. The babies in slow advancement group took longer time to 
regain birth weight (median difference 2-6 days) and  to establish full 
enteral feeds. 
Standard feeding practices 
Six studies (1978-2003) were analysed the incidence of stage II and 
III NEC in preterm, LBW neonates. Considerable heterogeneity including 
variation in the feeding practices were identified before and after 
implementation of a standard feeding regimen. A systematic review by 
Patole et al 26 indicated that any standard feeding regimen results in a 
29% (95% CI 3% to 48%) decrease in the risk of NEC. 
The reasons could be standard feeding regimen increases the 
awareness of clinician  regarding present evidence of feeding policies, 
changing from formula to breast milk and  early detection of NEC by 
implementing evidence based written  feeding protocols. 
Feeding in IUGR babies 
Growth restricted infants are at increased risk of developing NEC27  
and enteral feeding introduction was frequently delayed. 
In ADEPT trial28 400 babies, GA< 35 weeks with abnormal 
antenatal umbilical artery Doppler study allocated to an "early" or "late" 
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enteral feeding groups starting milk feeds on day 2 and day 6 after birth, 
respectively and feeds increased gradually.  In early group full feeds were 
achieved at an 18 days compared with 21 days in the late group. No 
difference was found in the incidence of NEC, particularly for serious 
Bell’s stage 2 or 3 and rates of all-stage NEC was 18% in the early group 
and 15% in the late group.  
Speed of Increasing Feeds Trial (SIFT) 
SIFT is a randomised controlled trial will enroll 2500 very preterm 
or VLBW infants. The trial will compare advancing enteral feeds at either 
30 ml/Kg/day or 18 ml/Kg/day. Both  human milk-fed and formula-fed 
infants will be eligible to participate. The primary outcome is death or 
moderate or severe disability at 2 years.  
Beneficial effects of breast milk 
Human milk empties from the stomach faster than formulas, so 
feedings can be advanced more easily, reach full feedings faster and need 
less intravenous fluids. Human milk fed infants spend fewer days in the 
hospital, less necrotizing enterocolitis, retinopathy of prematurity29 and 
sepsis. Anti infective properties of breast milk is due to the presence of 
higher amount of IgA, lysozyme and lactoferrin and various 
immunomodulatory factors 30, 31. Non- pathogenic bacteria from mother 
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transmitted via breast milk promotes enteromammary immune responses32.  
Breast fed babies tend to have improved cognitive skills and behavior 
ratings.  
Feeding human milk improve feed tolerance in preterm VLBW 
neonates. Schanler et al 33 in his study found that babies receiving at least 
50ml/Kg/day of human milk had decreased number of feed intolerance 
and reached full enteral feeds rapidly. Paula M. was able to show in 
neonates weighing ≤1250 grams, enteral feeding with minimum 50% 
maternal milk was associated with fewer days to full enteral feeding. The 
above studies emphasize the importance of breast milk in reducing feed 
intolerance. 
 Human milk benefits in preterm infants 
The long chain polyunsaturated fatty acids (LC-PUFA) like 
arachidonic acid and docosahexaenoic acid in breast milk improve the 
long term neurodevelopment outcomes. Since the accretion of LC-PUFA 
occurs during the third trimester, preterm babies are deficient in LC-
PUFA and are prone for neurodevelopmental impairment. Hence early 
enteral feeding in premature infants is associated with better neurological 
outcome. 
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      Cholesterol is an important component of myelin membranes 34 
and in the postnatal period increase in synapse number requires large 
amounts of cholesterol. Breast milk has significantly higher quantities of 
cholesterol compared to formula feeds 35. Hence breast milk plays an 
important role in white matter development and cognition, through 
enhanced glial production/myelination 34.  
           The practical difficulty of initiation of full enteral feeds is the 
adequacy of breast milk during the initial few days. Hence lactational 
encouragement and support for the mother is most important. The 
alternative is the use of donor breast milk which is the next best to 
biological mother’s milk (WHO) from human milk banks. 
Donor milk  
The first human milk bank opened in Vienna, Austria, in 1909. At 
present 517 human milk banks are present all over the world.  Asia’s first 
human milk bank was opened at Sion Hospital Mumbai on 27 Nov. 1989  
under the  guidance of Dr Armeida Fernandez there are 25 breast milk 
banks in our country at present.  
In a recent meta-analysis by Boyd et al36 reported that donor milk 
decreases the risk of NEC by about 79%.  In 1984, Narayanan et al 37 
showed pasteurized human milk gives protection against infection where 
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as when formula was added to pasteurized milk infection rate was 
increased. 
Clinical studies comparing donor milk and formula 
In a recent systematic review Boyd et al compared formula and 
donor milk feeding of VLBW babies. Formula fed babies had increased 
rates of weight gain, linear growth and head growth in short term where 
as there was no difference on long-term growth rates and 
neurodevelopmental outcomes. The study also confirmed that formula fed 
babies had 4-fold increased risk of NEC36. 
Schanler RJ 33 in a randomized controlled trial found that when 
mother’s own milk was supplemented either with preterm formula or 
donor milk the rate of late onset sepsis was similar between both the 
groups.    
The nutritional content of donor milk  
There is no standardization of the macronutrient and mineral 
content of the donor milk. Some trials showed significant variation in 
macronutrient content in donor milk mainly due to natural biologic 
variability. Some concern exists regarding the effects of heat treatment, 
particularly for proteins.  
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Nutritional components like Carbohydrates, fats, fat-soluble 
vitamins and salts are unaffected or only minimally reduced through the 
process of pasteurization whereas thirteen per cent of the protein content 
is denatured.   
Table 1: Various components of human milk after freezing and 
pasteurisation 38 
Component Level after freezing 
and pasteurisation 
IgA 67-100% 
IgM 0 
IgG 66-70% 
Lactoferrin 27-43% 
Lysozyme 75% 
Lipases 0 
Monoglycerides and 
Free fatty acids 
100% 
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STUDY JUSTIFICATION 
            The initiation and rate of progression of enteral feeds in preterm 
VLBW neonates is an area of clinical ambiguity. Enteral nutrition has 
been postponed due to fear of feed intolerance and the threat of 
necrotizing enterocolitis. Significant proportions of the babies acquire 
extra uterine growth restriction (EUGR). Thus, efforts should be focused 
on improving the early nutrition of these babies, allowing them to reach 
satisfactory growth rate. Optimizing feeding in this group of babies has 
short term and long-term health implications. Early enteral feeding and 
rapid advancement of feeding have shown to be beneficial in not only 
AGA babies but also in SGA, IUGR babies with abnormal umbilical 
artery Doppler study. It is also recommended by various systemic reviews 
and Meta analysis. Standardized feeding guidelines for VLBW neonates 
are lacking in the literature and heterogencity of feeding practices among 
various neonatal units’ results in difference in growth and various feed 
related issues. Some of these feeding practices are not based on evidence 
but based more on personal experiences or unit culture. 
This study was designed to compare the efficacy of full enteral 
feeds from day one of life in effecting early regain of birth weight 
compared to standard feeding in hemodynamically stable VLBW 
neonates.   
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Research Question:  
Does initiation of full enteral feeding with human milk from day 
one of life more effective than standard feed in regaining of birth weight 
in hemodynamically stable VLBW babies weighing between 1000-1500 
grams? 
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HYPOTHESIS AND OBJECTIVES 
Hypothesis:  
 In hemodynamically stable VLBW neonates weighing between 
1000-1500 grams   initiation of full enteral feeding with human milk from 
day one of life would be associated with rapid regain of birth weight 
when compared with infants receiving feeds according to the standard 
protocol. 
OBJECTIVES: 
Primary objective:  
To evaluate the effects of full enteral feed (60 ml/Kg/day of human 
milk on day one, 20ml/Kg/day during feeding advancement) started from 
day one of life (intervention) in enhancing the regain of birth weight 
compared to that of standard feed (both human milk feeds and 
intravenous fluid) in a group of hemodynamically stable VLBW babies 
with normal antenatal Doppler study.                  
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OUTCOME OF THE STUDY 
 Primary  Outcome :   
Number of days taken to regain  the birth weight in 
hemodynamically stable VLBW neonates  receiving  full enteral feeding 
from day one of life  compared to  neonates  receiving  standard  feeds. 
 Secondary outcomes:   
 To compare the following clinical outcome in the two groups                             
      1. Duration of hospital stay. 
      2. Incidence of Necrotising Enterocolitis (NEC) 
      3. Incidence of sepsis,  
      4. Need for intravenous fluid therapy. 
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METHODOLOGY 
Study title: Does full enteral feed from day one of life influence weight 
gain in hemodynamically stable VLBW babies weighing between 1000-
1500 grams as against standard feeding? 
Study Design: Open labeled randomized control trial 
Study centres: Department of Neonatology, Institute of Child Health 
(out born unit) and Institute of Obstetrics and Gynecology (inborn unit) 
of Madras Medical College, Chennai, Tamil Nadu, India.  
Duration of the Study: December 2013 to March 2014  
Materials & Methods:  
Subjects:   
Hemodynamically stable VLBW Neonates admitted to the 
newborn wards of the Institute of Child Health, Institute of Obstetrics & 
Gynecology, Egmore, Chennai. 
Inclusion Criteria:  
 Haemodynamically stable VLBW neonates weighing between 
1000 gms-1500gms. 
 Admission within 24 hrs of birth into the unit.     
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 Exclusion Criteria:  
 Major congenital malformation. 
 IUGR with abnormal antenatal Doppler. 
 Hypoglycemia requiring IVF therapy. 
 Need for intra-uterine transfusion.  
Sample Size:  
Sample size was calculated with the hypothesis that starting 
VLBW babies on full enteral feeding with human milk was associated 
with shorter duration to regain birth weight.  It was assumed that full 
enteral feed babies regained the birth weight in 12 days with standard 
deviation of 2.5 days and standard feed babies regained the birth weight 
in 14 days with standard deviation of 3 days with the significance level of 
5%(α = 0.05) and the power of 80%(β = 0.2), the required sample size for 
two sided is 30 in each group. We enrolled 69 babies in the study after 
randomization. 
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Recruitment and randomization: 
Informed written consent for the trial was obtained within the first 
24 hours of birth from the parents or care givers. The parents were given 
verbal explanation about the relevance of the study, benefits and the 
possible adverse effects by the recruiting clinician. The information sheet 
was printed in both Tamil and English.  After getting consent the babies 
were randomized and enrolled for the study. 
Neonates satisfying the inclusion criteria were randomly allocated 
to receive feed under any of the two protocols - full enteral feeding group 
or standard feeding group as per the randomization sequence obtained 
after opening the sealed envelope. The computer generated randomization 
sequences with blocks of varying size were inside the envelopes to which 
the investigator was blinded.  
 Intervention:  
After getting written consent for the trial, babies were randomized 
and enrolled within 24 hours of birth. Consent was also obtained for use 
of the donor human milk which was processed. Donor health, history for 
life style risks and blood screening tests were all assessed similar to a 
blood donor.  Donors were educated regarding the hygienic methods in 
which milk expression and collection had to be done. Both hand 
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expression and electrical milk bumps were used for milk expression.  
Expressed breast milk collected from donors was pooled into sterile 150 
ml stainless steel vessels. It was pasteurized (This pasteurization method, 
known as flash-heat method  involves heating milk in a water bath and 
holding it  for 30 minutes at 62°C) and rapidly freezed  to -17 degree and 
stored. During collection an aliquot of pooled milk was removed from 
each batch and separately poured into a small container and this milk was 
also pasteurized (Pilot bottle). Milk from the pilot container was sent for 
microbiological testing. The milk was discarded if any bacterial growth 
was present.   
  Pasteurized, frozen milk was thawed by keeping the container in 
lukewarm water.  Frozen milk was not thawed at room temperature as 
this can result in bacterial contamination. Thawed milk was used within 
4-6 hrs.   Pasteurized donor milks were stored in the freezer after proper 
labeling with identification number, pasteurization date and milk culture 
reports. 
 
  
23 
 
             
 
 
 
 
Pasteurisation 
 
 
 
 
Human milk storage in freezer 
 
 
 
 
 
 
24 
 
Full enteral feeding group (study group) 
Babies were started on enteral feeds with human milk at the rate of 
60ml/Kg/day from day one, and progressed by increments of 20 
ml/Kg/day until maximum enteral feeds of 180 ml/Kg/day was achieved. 
Standard feed group (1000-1200 gram) 
Babies were started with human milk feeds at the rate of 
20ml/Kg/day on day one along with intravenous fluid of 60 ml/Kg/day. 
(Total fluid 80ml/Kg/day) Enteral feeds were increased by increments of 
20 ml/Kg/day until maximum enteral feeds of 180 ml/Kg/day was 
achieved.  
Standard feed group (1200-1500gms) 
Babies were started on human milk feeds at the rate of 
40ml/Kg/day along with intravenous fluids 40 ml/Kg/day from day one 
and human milk feeds were increased by 20 ml/Kg/day until maximum 
enteral feeds of 180 ml/Kg/day was achieved. 
All the babies were fed with human milk only (either mother’s own 
milk or pasteurized donor milk if mother’s own milk was not available). 
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Gastric residual 
When gastric aspirate volume was 2-3 ml or less and the clinical 
condition of the baby is stable, enteral feeds were continued. If the 
volume of gastric aspirate was 30-50% of pre feed volume and/ or 3 
ml/Kg, then the volume of human milk feed was not increased over the 
following 24 hours. 
Indications for withholding feed (two or more of the following) 
 If the volume of gastric aspriates was above 50% of feed volume, 
Increase in abdominal girth measured at the umbilicus by 2 cm or 
more from baseline in 6 hours interval,  
  Visible dilated  bowel loops or significant emesis, 
  Minimal blood tinged or coffee ground aspirate. 
Episode of NEC (VLBW babies who had clinical symptoms of 
necrotising enterocolitis (NEC), i.e., at least two of the following signs: 
vomiting, abdominal distention, pre-feeding residuals, redness of flanks, 
persistent microscopic or gross blood in stools; and at least one of the 
following criteria: pneumoperitoneum, pneumatosis intestinalis, 
unchanging ‘rigid’ loops of small bowel), duration of hospital stay, 
number of days on IVFs, incidence of  sepsis defined as in an infant 
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having clinical picture suggestive of septicemia, pneumonia or meningitis 
along with either of the following - Isolation of pathogens from blood or 
CSF or urine or abscess (es) during the study period were monitored.  
Except for the feeding protocol, other managements in two groups 
were the same as per unit policy. If any troublesome effect was noted in 
the study group, then the unit protocol was followed till the time of 
recovery and the feeds were then started as in the study group.  The 
primary and secondary outcomes of the trial were analysed in 
intervention and control groups. The risks involved were minimal as 
mentioned in previous studies. Before giving feed, abdominal girth 
measurement was done. If there was an increase in abdominal girth above 
2 cm, then gastric aspiration was done. 
Caregivers were not blinded to the randomized allocation, but the 
personnel involved in analysis were blinded. Babies were studied during 
the period of hospitalization and data was collected from the baby’s 
medical chart. 
During the study period, the following data were monitored - daily 
weight measurement, second hourly abdominal girth measurement, 
gastric aspirates, significant vomiting, apnea, time taken to reach full 
enteral feedings, feeding  details and fluids intake (both intravenous and 
enteral feed).  
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Anthropometry (weight, length and head circumference) was 
recorded at birth. The weight was measured using Neotech electronic 
weighing scale which can read up to 5 grams.  Calibration of the 
weighing scale was done at regular intervals. Weight was measured daily 
by trained nurses or doctors. Weight was recorded twice daily until the 
infant regained birth weight. Length was recorded to an accuracy of 1mm 
using infantometer weekly and the head circumference was recorded to 
an accuracy of 1 mm using non stretchable measuring tape weekly. 
Intrauterine growth status was assessed using the Fenton Growth Chart. 
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CONSORT FLOW DIAGRAM 
                 
    
 
                                                                                                    excluded           
                                                                                                                                                                                                                            
 
 
 
 
 
  
Assessed for eligibility 
(N=204) 
VLBW neonates 
No of eligible neonates (N=103) 
Hemodynamically stable VLBW 
           Randomization 
 
Excluded -34                                                                                
Major congenital malformation   - 5                           
IUGR with abnormal antenatal Doppler -14                                                                                                  
Hypoglycemia   requiring   IVF therapy -15 
No of neonates enrolled (N=69) 
Strata A =19 (1000-1200)                     Strata B =50 (1200-1500) 
Allocated to control (N-35) 
Unit protocol feeding gp (A 9+B 26) 
Allocated to intervention (N -34) 
Full enteral feeding gp (A 10+ B 24) 
Died -2 Died -2 
Analysed for regain of birth weight 33                     
Days taken to regain birth weight 
16.3 (± 4.12) 
Days taken to regain birth weight 
14.18 (±3.53) 
Analysed for regain of birth weight 32 
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RESULTS AND ANALYSIS 
204 babies were assessed for eligibility and 103 babies were found 
to be eligible as per the inclusion criteria. 34 babies were excluded in 
view of major congenital malformations (5), IUGR with abnormal 
antenatal Doppler (14) and hypoglycemia requiring IVF therapy (15). We 
enrolled 69 babies for the study. The enrolled babies were stratified based 
on birth weight. 19 babies had birth weight between 1000 to 1200gm. 50 
babies had  birth weight between 1200 to 1500gm . These babies were 
randomly assigned to the intervention and control groups. Thirty four 
babies were in the full enteral feeding group (intervention) and thirty five 
babies were in the standard feeding group (control).  32 babies (2 deaths) 
in intervention group and 33 babies (2 deaths) in control group were 
available for analysis of primary outcome.    
The data are presented as numbers (percentage) for categorical 
variables, or means (SD) for normally distributed continuous variables 
and median (IQR) when the distribution was skewed. 
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Maternal characteristics 
Baseline maternal variables like age, parity, complications and 
steroid administration were comparable in intervention and control 
groups  
Table : 1 Baseline Maternal Characteristics 
Variable 
Full enteral 
feeding  n-34 
N (%) 
Standard feeding 
n-35 
N (%) 
P value 
 Age in years* 24.61 (±4.11) 25.14 ( ±4.50) 0.61 
Primi 21(61.8%) 18(51.4%) 0.46 
Anaemia 12 (35.3%) 13(37.1%) 1 
Hypertension 12 (35.3%) 14(40%) 0.87 
Diabetes mellitus 1 (2.9%) 1(2.9%) 1 
Antenatal 
steroids 
Partial 
Complete 
 
 
16 (47.1%) 
7 (20.6%) 
 
 
18 (51.4%) 
5 (14.3%) 
 
 
0.78 
Infection 
Fever 
P PROM 
 
3(8.8%) 
5(14.7%) 
 
2 (5.7%) 
8 (22.8%) 
 
0.84 
Oligohydramios 3 (8.8%) 2 (5.7%) 0.67 
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Table : 2 Baseline Neonatal Characteristics 
Variable 
Full enteral 
feeding n-34 
N (%) 
Standard feeding 
n-35 
N (%) 
P value 
Male 18(52.9 %) 20 (57.1 %) 0.91 
Birth weight (gms)* 1290 (±153.7) 1308 (±150.5) 0.63 
Gestational age 
(wks)* 31.4 (±1.8) 31.9 (±2) 0.21 
Growth status 
AGA 
SGA 
 
27 (79.4%) 
7(20.6%) 
 
27   (77.2%) 
8 (22.8%) 
0.72 
Mode of delivery 
Vaginal delivery 
LSCS 
 
22 (64.7 %) 
12 (35.3%) 
 
20 (57.1%) 
15 (42.1%) 
 
0.69 
Apgar< 7 at 5 mts 3(8.8%) 2(5.7%) 0.67 
Out born 8 (23.5%) 11 (31.4%) 0.64 
*-Mean / SD 
The neonatal demographic variables that could affect regain of 
birth weight were evenly distributed and there was no statistical 
difference between two groups.  
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Table : 3 Intervention during study period 
Co 
intervention 
Full enteral 
feeding  n-34 
N (%) 
Standard feeding 
n-35 
N (%) 
P value 
CPAP days 
     < 3 days 
    3- 7 days 
    >7 days 
 
10 (29.4%) 
9 (26.5%) 
3 (8.8%) 
 
12 (34.3%) 
5 (14.3%) 
2 (5.7%) 
 
0.30 
Ventilation 
days 
     < 3 days 
     3- 7 days 
     >7 days 
 
 
2(5.9%) 
7(20.6%) 
1(2.9%) 
 
 
6 (17.1%) 
3 (8.6%) 
3 (8.5%) 
 
 
0.39 
 
Babies receiving interventions like CPAP and invasive ventilation were 
evenly distributed in both the groups. 
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Table : 4 Mortality 
Parameter 
Full enteral feeding 
n -34 
N (%) 
Unit protocol feeding 
n -35 
N (%) 
P value 
Mortality 4 (11.8%) 3 (8.6%) 0.710 
 
Four babies died in full enteral feeding group and three babies died 
in standard feeding group (p - 0.7). Mortality between the two groups is 
not statistically significant. 
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Table : 5 Primary outcome 
Variable Full enteral feeding (n -32) 
Standard  feeding 
(n - 33) P value 
Days taken to 
regain birth 
weight* 
14.18  (±3.53) 16.33 (± 4.12) 0.028 
*-Mean (SD), Calculated from amongst the babies completing the trial. 
Full enteral feeding group regained birth weight at a mean age of 
14±3.58 days and standard feeding group at a mean age of 16 ±4.12. 
Babies regained their birth weight two days earlier in full enteral feeding 
group than the standard feeding group and this difference was statistically 
significant (P - 0.028). 
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Table : 6 Secondary outcomes 
Variable 
Full enteral 
feeding 
(n - 34) 
Standard  feeding 
(n - 35) P value 
Duration of 
hospital stay* 19.76 ±(6.69) 20.71(7.71) 0.58 
IVF days** 2 ( 0-7.75 ) 6 ( 5-9 ) 0.068 
Sepsis 
Clinical sepsis 
Culture +ve 
sepsis 
 
9 (26.5%) 
6 (17.64%) 
 
15 (46.9%) 
3 (15%) 
 
0.29 
0.71 
*- Mean (SD), **- median (IQR) 
Full enteral feeding group infants had lesser days of intravenous 
fluids compared to babies in the standard feeding group. However, it was 
not statistically signiﬁcant. There was no difference in incidence of 
clinical or culture positive sepsis and duration of hospital stay. None of 
the babies in our study series developed necrotizing enterocolitis. We 
used only human milk for feeding in both the groups. 
Subgroup analysis: 
Two stratified groups were analysed separately. Group A (n-19) 
(birth weight between 1000 – 1200gms) 10 babies were enrolled in the 
full enteral feeding group and 9 babies in the standard feeding group  
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Table : 7 Subgroup analysis for group A: (1000 – 1200gms) 
 
Group A 
(1000-1200gms) 
N -19 
Full enteral 
feeding 
N -10 
Standard feeding 
N-9 P Value 
Birth weight 1.08± 
71(grams) 
1.09±64(grams) 0.87 
Gestational age  30±1.7 (weeks) 30±1.87 (weeks) 0.81 
Apgar  <7 at 5 
minutes 
2(20%) 1(11.1%) 0.58 
SGA 
AGA 
6 
4 
7 
2 
 
0.58 
Antenatal  
steroids 
Partial course 
Full course 
 
 
5(50%) 
2(20%) 
 
 
6(66.7%) 
1(11.1%) 
 
 
 
0.75 
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Table : 8 Primary outcome (1000-1200 grams) 
Parameter 
Full enteral 
feeding 
N-8 
Standard feeding 
N-7 P value 
Days taken to 
regain birth 
weight* 
 
17.37(±4.9) 
 
19.8 (±4.3) 
 
0.32 
 
*Mean (SD), Calculated from amongst the babies completing the trial. 
  Full enteral feeding group regained birth weight at a mean age of 
17.37 ± 4.9 days and in the standard feeding group, birth weight was 
regained at a mean age of 19.8 ±4.3. Babies regained their birth weight 
two days earlier in full enteral feeding group than standard feeding group 
and this was not statistically significant.  
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Table : 9 Secondary outcome (1000-1200gms) 
Parameter 
Full enteral 
feeding 
(n - 10) 
Standard 
feeding 
(n - 9) 
P value 
Hospital stay**(days) 22 (15- 28) 27 (22-33) 0.43 
Sepsis 2 (20%) 1 (11.1%) 0.76 
IVF days** 10 (1.5-17.75) 6 (4.5-16.5) 0.88 
 
*- Mean (SD), **- median (IQR)  
Full enteral feeding group had longer duration of intravenous fluids 
compared to babies in the standard feeding group. However, it is not 
statistically signiﬁcant. There was no difference in incidence of clinical 
and culture positive sepsis, death, duration of hospital stay. None of the 
babies in our study developed necrotizing enterocolitis. 
Subgroup analysis:                                                                      
Group B 50 babies were enrolled (birth weight 1200 - 1500gms).   
24 babies in full enteral feeding group and 26 in standard feeding group   
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Table : 10 Subgroup analysis (birth weight 1200-1500 gms) 
Group B 
(1200-1500gms) 
n-50 
Full enteral 
feeding 
n-24 
Standard 
feeding 
n-26 
P value 
Birth weight 1.37±79 1.38±85 0.77 
Gestational age  31.87±1.65 32.53±1.86 0.19 
SGA 
AGA 
4(16.7%) 
20(83.3%) 
5(19.2%) 
21(80.8%) 
0.97 
Antenatal steroids 
Partial course 
Full course 
 
11(45.8%) 
5(20.8%) 
 
12(46.2%) 
4(15.4%) 
 
0.86 
 
 
Tables : 11 Primary outcome (1200-1500gms) 
 
Variable 
Full enteral 
feeding 
(n -  24) 
Standard feeding 
(n - 26) 
P value 
Days taken to 
regain birth 
weight* 
 
13.12 ±2.17 
 
15.38 ±3.57 
 
0.009 
 
*Mean (SD), Calculated from amongst the babies completing the trial. 
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  Full enteral feeding group regained birth weight at a mean age of 
13.12±2.17 days and in standard feeding group at a mean age of 15.38 ± 
3.57. Babies regained their birth weight two days earlier in full enteral 
feeding group than standard feeding group and this was statistically 
significant (P - 0.009). 
Table : 12 Secondary outcome   (1200-1500gms) 
Parameter 
Full enteral 
feeding 
(n - 24 ) 
Standard feeding 
(n - 26 ) 
P value 
Hospital stay* 
(days) 
18.62 ±4.08 18.73 ±5.44 0.93 
Culture positive 
sepsis 
4 (16.7%) 2 (7.7%) 0.12 
IVF days** 1 (0-3.75) 6 (4.75-8.2) 0.003 
 
*- Mean (SD), **- Median (IQR) 
Full enteral feeding group babies had lesser number of days of 
intravenous fluids compared to babies in standard feeding group. It was 
statistically signiﬁcant (P - 0.003). 
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There was no difference in incidence of culture positive sepsis, 
duration of hospital stay. None of the babies in our study developed 
necrotizing enterocolitis. 
  
42 
 
DISCUSSION 
Our study compared stable VLBW babies who were fed full enteral 
feeding from day one using mother’s own milk and banked human milk 
with standard feeding group and has shown that, babies achieved earlier 
regain of birth weight in full enteral feeding.  The full enteral feeding 
regimen was safe with no differences in the incidence of NEC, sepsis and 
other feed related morbidities. 
Regain of birth weight  
                 Our study has showed that babies in the full enteral feeding 
group regained their birth weight at 14.18 days and in the standard 
feeding group at 16.33 days (P - 0.028).   This difference was statistically 
significant.  There have been very few published studies evaluating the 
days required to regain birth weight while on full enteral feeds from day 
one.  
          Sanghvi KP et al study 39 found that in babies with birth weight 
between 1200 -1500 grams, full enteral feed group regained birth weight 
7 days earlier than the babies in the control group.  In the 1200-1500 
grams subgroup analysis in our study, babies regained birth weight at a 
mean age of 13.1 days in full enteral feeding group and 15.4 days in 
standard feeding group. The difference was probably because we started 
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on 60 ml/Kg/day on day one and advanced at a rate of 20 ml/Kg/day 
where as in their study, the starting volume was 80 ml/Kg/day and the 
feed advanced at a rate similar to our study.  Other reasons could have 
been the higher incidence of maternal hypertension (36%), poor antenatal 
steroid coverage (complete course in 20%) and higher proportion of SGA 
(16%) in our 1200-1500 subgroup babies.   
           Previous studies have reported that maternal hypertension 
increased the time taken to achieve full enteral feeds by 11.2%. The 
reason could be that the abnormality of the umbilical artery blood flow in 
utero may continue in the splanchnic circulation even after birth for some 
days compromising feeding tolerance and full enteral feeding 
attainment 40. 
           Similarly in Wang et al study 18, early enteral feeding neonates 
regained their birth weight at 20 days in the 1000 – 1250 grams group.  In 
our study babies in the 1000-1200 grams subgroup regained birth weight 
by 17 days.  This earlier regaining of birth weight in our study could be 
due to the use of exclusive human milk compared to either breast milk or 
preterm formula in Wang et al study. 
Morgan et al 15 in the meta analysis studied the effects of slow 
enteral feed advancements (15 to 20 ml/Kg/day) and concluded that 
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infants in the slow advancement group took more days to regain birth 
weight (median difference two to six days). 
          Leaf A 24 et al studied the early and late enteral feeds in preterm 
(GA 31 wks) SGA babies with abnormal antenatal umbilical artery 
Doppler waveforms and concluded that babies in the early enteral feed 
group had better weight score and had lesser days of parenteral nutrition. 
There was no difference in the incidence of NEC.   
          Salhotra et al 41 found that babies in the fast enteral feeding group 
regained birth weight earlier (median 18 days) after their study of Indian 
infants. They used only expressed breast milk for enteral feeds. 
Krishnamurthy S 42et al also concluded that VLBW neonates in the rapid 
advancement group (30ml/kg/day) regained birth weight   earlier (median 
16 days vs. 22 days) in their study using expressed human milk or 
formula.   
          Our study was comparable with that of an unpublished study done 
in a tertiary hospital in Mumbai by Joshi et al.  In their study, infants in 
the full enteral feeding group regained birth weight earlier (mean 5.52 
days) than those in the standard feed group (mean 12.7).  The difference 
was statistically significant (p<0.0001) as in our study. This study 
enrolled only preterm infants with birth weight 1200 to 1500 grams. 
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Duration of hospital stay and intravenous fluid 
   In our trial the number of days of hospital stay was lesser in the 
full enteral feed group compared to the standard feed group, though it 
was statistically insignificant (19.76 days in full enteral feeding group 
and 20.71 days in standard feed group). Similarly, the duration of 
intravenous fluid administration was lesser in the full enteral feed group 
compared to the standard feed group though not statistically significant. 
 In the randomised trial by Caple et al 43 comparing slow and rapid 
feeding volume progression in preterm infants, it was found that babies in 
the rapid feed advancement group had lesser intravenous fluid days. The 
length of hospital stay was lesser in the rapid feed advancement group 
though it was not statistically significant. Similar results were obtained in 
the study by Karagol BS et al 44 on comparing slow versus rapid feed 
advancement in VLBW babies with birth weight 750gms -1250gms. 
                 In Sanghvi KP39 et al study the number of days in hospital was 
significantly less in the full enteral feeding group (mean 15.04 days, SD ± 
5.26). But in the control group, the mean duration of hospital stay (mean 
28.04 days, SD ± 6.76) was relatively high when compared to our sub 
group babies of 1200-1500 grams birth weight where babies in full 
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enteral feed and standard feed groups regained birth weight 18.62 days 
and 18.73 days respectively.  
                 Krishnamurthy S 42 et al, while comparing rapid and slow 
progression of enteral feeding, found a significantly lesser number of IVF 
days (median 2 days vs. 3.4 days) (p < 0.001), and shorter hospital 
stay(median 9.5 days vs. 11 days) (p = 0.003) in the rapid advancement 
group using either human milk or formula. 
Sepsis 
 In our study, there was no statistically significant difference 
in the incidence of infection between the full enteral feed group(17.64%) 
and standard feed group (15%). The reason could be earlier the use of 
human milk in both the groups. Lavole et al 44 studied the relationship 
between early enteral nutrition and CoNS associated late onset 
bacteremia in VLBW infants. The early nutrition group reached full 
enteral nutrition earlier and early initiation of enteral nutrition with 
human milk had reduced the incidence of late onset bacteremia. The next 
important observation of this study was when enteral nutrition was 
initiated earlier with formula feed, there was no reduction in the incidence 
of late onset bacteremia. 
47 
 
 Karagol et al 45 while studying on rapid feed advancement found 
that the incidence of sepsis (culture positive) was less in the rapid feeding 
group. Hylander et al 46 in his study comparing the presence of infection 
in human milk feed and formula feeds concluded that human milk 
feeding had reduced odds of infection. 
  An unpublished study was done by Chetry et al in New Delhi 
comparing initiation of total enteral feeds on 1st day of life with standard 
feeding regimen in VLBW infants. In this study the incidence of culture 
proven sepsis was higher in the standard feeding regimen group with 
higher number of days in intravenous fluids with borderline significance 
(31.8% vs. 15%, p-0.28). 
Necrotizing enterocolitis 
 There was no incidence of NEC in our study. This could be due to 
the use of exclusive breast milk. Lucas et al47 found  a 6-10 fold increase 
in necrotizing enterocolitis in babies receiving formula feeds  and a 3 fold 
increase in those who received formula plus breast milk compared to 
breast milk only. Pasteurized donor milk is similar to raw maternal milk 
with regards to the risk of NEC.    
Leaf A 24 et al conducted a study on initiation of early enteral feeds 
(within day 2) in Small Gestational age neonates with abnormal umbilical 
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artery Doppler study. The study concluded that there was no difference in 
the risk of necrotizing enterocolitis. The Cochrane review by Morgan et 
al suggested that there was no difference in the risk of NEC between slow 
and rapid progression of enteral feeds.  
 Sisk et al48 wanted to determine if high proportions of (50% or 
greater) human milk enteral feeding initiated during first 2 weeks of life 
offered protection against NEC. They concluded that feeding with at least 
50% human milk was associated with a six fold reduction in the risk of 
NEC. This could explain the zero incidence of NEC as both groups in our 
study group had exclusive breast milk feeding. In the study conducted by 
Leaf et al24 in preterm growth restricted infants, there was no difference 
in the incidence of NEC among those who were fed early or late. 
  In Sanghvi KP et al39 study which was done with full enteral 
feeding from the initial few hours of life, none of the babies developed 
necrotizing enterocolitis. This was replicated in our study as well. 
Boo NY et al49  studied  the risk factor associated with feed 
intolerance in VLBW  babies was due to the delay in starting the first 
feed  and  suggested  that to promote tolerance, enteral feeds  should be 
started as soon as possible during the first 72 h of life.  
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The strengths of our study were 
 This was a well-designed, randomized control trial with adequate 
sample size. 
 This is one of the few studies done with exclusive breast milk. The 
breast milk bank in our unit ensured adequate breast milk. 
 The strict adherence to feeding policies helped us in comparing 
the full enteral feeds with standard protocol. 
The limitations of our study were: 
 The donor milk was not classified as term and pre term milk. 
Hence a difference in the protein and caloric contents might have 
had an influence on the outcomes. 
 Since different clinicians assessed the feed intolerance and other 
outcomes, there might have been observer bias. 
 Long term neurological outcomes were not studied. 
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CONCLUSION 
Full enteral feeding from day one of life in hemodynamically  
stable very low birth weight babies with exclusive human milk (both 
maternal and donor milk) results in fewer days to regain birth weight.  
There is also no evidence that full enteral feeding has adverse 
effects particularly on the risk of necrotizing enterocolitis. We conclude 
that initiating full enteral feeding practice is an effective, feasible, cost 
effective and safe intervention.  
There is less chance of NEC even in growth restricted babies with 
this schedule. Hence it would be prudent to commence full enteral 
feeding from first day of life and prevent inadequate nutrition in this 
critical period of growth. 
IMPLICATIONS FOR PRACTICE: 
1. Full enteral feeding can be initiated from day one in 
hemodynamically stable VLBW neonates safely with careful 
monitoring. 
2. Full enteral feeding with standardized feeding guidelines 
minimizes the feed related morbidities. 
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3. The practice of full enteral feeding from day one would provide an 
encouragement for exclusive breast feeding policy among the care 
givers and the mothers. 
4. A donor breast milk bank with preterm and term milk will be of 
more use. 
IMPLICATIONS FOR FURTHER RESEARCH: 
A larger randomized controlled trial with more number of babies 
would provide us with a better knowledge of the secondary outcomes like 
duration of hospital stay and incidence of sepsis.  
The donor milk diet may be a variable in terms of caloric and 
protein content and the nutritional components of donor milk may be 
altered by pasteurization. Hence a study analyzing the nutrient contents of 
the donor milk would be of more use. Further studies with fortified donor 
human milk would also provide us additional information.  
A long term follow up study analyzing the growth and 
neurodevelopmental outcome would provide us the impetus to use breast 
milk from day one of life.  
 
  
52 
 
BIBLIOGRAPHY 
1.  American Academy of Pediatrics Committee on Nutrition: 
Nutritional needs of low-birth-weight infants. Pediatrics 1985; 
76:976–986. 
2. Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of the 
very low birthweight infant. Clin Perinatol. 2002;29:225-244.  
3. Radmacher PG, Rafail ST, Adamkin DH. Postnatal malnutrition 
of extremely low  birth-weight infants with catch-up growth 
postdischarge. J Perinatol. 2003;23:477-482  
4.  Johnson LR. The trophic action of gastrointestinal    
hormones. Gastroenterology.1976 Feb;70(2):278–288.  
5.  Lucas A, Bloom SR, Aynsley-Green A. Gut hormones and 
‘minimal enteral feeding’ Acta paediatrica Scandinavica. 1986 
Sep;75(5):719–723.  
6. Berseth CL. Neonatal small intestinal motility: motor responses 
to feeding in term and preterm infants. J Pediatr. 1990 
Nov;117(5):777–782.  
53 
 
7.  Dusick AM, Poindexter BB, Ehrenkrantz RA, Lemons JA. 
Growth failure in the preterm infant: can we catch up? Semin 
Perinatol.2003;27 (4):302– 310 
8 Fanaro S. Which is the ideal target 
or preterm growth? Minerva Pediatr. 2010;62:77–82    
9.  Ehrenkranz R, Das A, Wrage L, Poindexter BB, Higgins RD, et 
al. (2011) Early nutrition mediates the influence of severity of 
illness on extremely LBW infants. Pediatr Res 69: 522–9. 
 10. Richard A. Ehrenkranz, Growth in the Neonatal Intensive Care 
Unit Influences Neurodevelopmental and Growth Outcomes of 
Extremely Low Birth Weight Infants PEDIATRICS Volume 117, 
Number 4, April 2006 
  11.  Kandasamy Y (2009) Infection control during administration of 
parenteral nutrition in preterm babies. Arch Dis Child Fetal 
Neonatal Ed. 94: F7. 
 12. Berseth CL, Nordyke C: Enteral nutrients promote postnatal 
maturation of intestinal motor activity in preterm infants. Am J 
Physiol 1993, 264:G1046-51  
54 
 
 13.  Dunn L, Hulman S, Weiner J, Kliegman R: Beneficial effects of 
early hypocaloric enteral feeding on neonatal gastrointestinal 
function: preliminary report of a randomized trial.J 
Pediatr 1988, 112:622-9.  
  14.   Meetze WH, Valentine C, McGuigan JE, Conlon M, Sacks N, 
Neu J: Gastrointestinal priming prior to full enteral nutrition in 
very low birth weight infants. J Pediatr Gastroenterol 
Nutr 1992, 15:163-70  
  15. Morgan J, Bombell S, McGuire W Early trophic feeding versus 
enteral fasting for very preterm or very low birth weight 
infants. Cochrane Database Syst Rev 2013;3:CD000504. 
16.  Noy Y, Geyra A, Sklan D. The effect of early feeding on growth 
and small intestinal development in the post-hatch poult. Poult 
Sci 2001;80:912–19. 
17.  Peitersen B, Bohn L, Andersen H. Quantitative determination of 
immunoglobulins, lysozyme, and certain electrolytes in breast 
milk during the entire period of lactation, during a 24-hour 
period, and in milk from the individual mammary gland. Acta 
Paediatr Scand. 1975;64:709–717 
55 
 
18.  Wang LY,  Clinical experience with early enteral feeding in 
very-low-birth-weight infants.Zhonghua Min Guo Xiao Er Ke Yi 
Xue Hui Za Zhi. 1997 Jul-Aug; 38(4):282-7 
 19. De Nisi G, Berti M, De Nisi M, Bertino E. Early enteral feeding 
with human milk for VLBW infants. J Biol Regul Homeost 
Agents. 2012 Jul-Sep;26(3 Suppl):69-73. 
20. Berrington JE, Stewart CJ, Embleton ND, et al. Gut microbiota in 
preterm infants: assessment and relevance to health and disease. 
Arch Dis Child Fetal Neonatal Ed 2013;98:F286–90.  
21. Henderson G, Craig S, Brocklehurst P, et al. Enteral feeding 
regimens and necrotising enterocolitis in preterm infants: a 
multicentre case-control study. Arch Dis Child Fetal Neonatal Ed 
2009;94:F120–3. 
22 . Kaufman SS, Gondolesi GE, Fishbein TM.Parenteral nutrition 
associated liver disease. Semin Neonatol. 2003;8(5):375–381 
23.  Morgan J, Young L, McGuire W. Delayed introduction of 
progressive enteral feeds to prevent necrotizing enterocolitis in 
very low birth weight infants. Cochrane Database Syst Rev 
2013;5: CD001970. 
56 
 
24. Leaf A, Dorling J, Kempley S, et al Abnormal Doppler Enteral 
Prescription Trial Collaborative Group. Early or delayed enteral 
feeding for preterm growth-restricted infants: a randomized 
trial. Pediatrics 2012;129:e1260–8. 
25.  Morgan J, Young L, McGuire W. Slow advancement of enteral 
feed volumes to prevent necrotizing enterocolitis in very low 
birth weight infants. Cochrane Database Syst Rev 
2013;3:CD001241. 
26. Patole SK, de Klerk N. Impact of standardised feeding regimens 
on incidence of neonatal necrotising enterocolitis: a systematic 
review and meta-analysis of observational studies. Arch Dis 
Child Fetal Neonatal Ed. 2005 Mar;90(2): 
27.  Dorling J, Kempley S, Leaf A (2005) Feeding growth restricted 
preterm infants with abnormal antenatal Doppler results. Arch 
Dis Child Fetal Neonatal Ed 90: F359–63. 
28. Leaf A, Dorling J, Kempley S, et al. Early orlate enteral feeding 
for preterm growth restricted infants? The Abnormal 
DopplerEnteral Prescription Trial (ADEPT). Arch Dis Child 
2010;95:A3 
57 
 
29.  Hylander MA, Strobino DM, Pezzullo JC, Dhanireddy R 
Association of human milk feedings with a reduction in 
retinopathy of prematurity among very low birthweight infants. J 
Perinatol. 2001 Sep;21(6):356-62. 
30. Groer M, Walker WA. What is the role of preterm breast milk 
supplementation in the host defenses of pre term infants? Science 
vs. fiction. Adv Pediatr 1996;43:335–58. 
31.        Kelleher SL, Lonnerdal B. Immunological activities associated 
with milk. Adv Nutr Res 2001;10:39–65. 
32. Mathur B, Dwarkadas AM, Sharma VK, et al. Anti-infective 
factors in preterm human colostrum. Acta Paediatr Scand 
1990;79:1039–44. 
33.  Schanler RJ, Lau C, Hurst NM, et al. Randomized trial of donor 
human milk versus preterm formula as substitutes for mothers’ 
own milk in the feeding of extremely premature infants. 
Pediatrics 2005;116(2):400–6. 
34. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, 
Wehr MC, Wieland F, Ishibashi S, Klaus-Armin N. High 
cholesterol level is essential for myelin membrane growth. Nat 
Neurosci. 2005;8:468–475.  
58 
 
35. Uauy R, Mize CE, Castillo-Duran C. Fat intake during childhood: 
metabolic responses and effects on growth. Am J Clin 
Nutr. 2000;72:1354S–1360S 
36. Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk versus 
infant formula for preterm infants: systematic review and meta-
analysis. Arch Dis Child Fetal Neonatal Ed 2007;92:F169–75. 
37. Narayanan I, Prakash K, Murthy NS, et al. Randomised 
controlled trial of effect of raw and Holder pasteurised human 
milk and of formula supplements on incidence of neonatal 
infection. Lancet. 1984;2:1111–1113 
38. Tully DB et al J Hum Lact 2001; 17: 152-155 
 39. Sanghvi KP, Joshi P. Feasibility of exclusive enteral feeds from 
birth in VLBW infants >1200 g--an RCT. Acta Paediatr. 2013 
Jul;102(7):e299-30 
  40. Ersch J, Baenziger O, Bernet V, Bucher HU (2008) Feeding 
problems in preterm infants of preeclamptic mothers. J Paediatr 
Child Health 44: 651–5. 
. 
59 
 
41.  Salhotra.A and Ramji.S Slow versus Fast Enteral Feed 
Advancements in Very Low Birth Weight Infants: A Randomized 
Controlled Trial. Indian Pediatrics 2004; 41:435-441 
42. Krishnamurthy S et al. Slow versus rapid enteral feeding 
advancement in preterm newborn infants  1000-1499 g: a 
randomized controlled trial. Acta Paediatrica, 2010, 99:42-46 
43. Caple J, Armentrout D, Huseby V.Randomized, Controlled Trial 
of Slow Versus Rapid Feeding Volume Advancement in Preterm 
Infants Pediatrics2004; 114: 6 
44. Lavoie PM. Earlier initiation of enteral nutrition is associated 
with lower risk of late-onset bacteremia only in most mature very 
low birth weight infants.J Perinatol. 2009 ;29(6):448-54 
45.  Karagol BS, Zenciroglu A, Okumus N, Polin RARandomized 
controlled trial of slow vs rapid enteral feeding advancements on 
the clinical outcomes of preterm infants with birth weight 750-
1250 g. JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):223-8. 
46. Hylander MA Human milk feedings and infection among very 
low birth weight infants, Pediatrics. 1998 Sep;102(3):E38. 
60 
 
47. Lucas A, Cole TJ Breast milk and neonatal necrotising 
enterocolitis. Lancet. 1990 Dec 22-29;336(8730):1519-23. 
48. Sisk PM1, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. 
Early human milk feeding is associated with a lower risk of 
necrotizing enterocolitis in very low birth weight infants. J 
Perinatol. 2007 Jul;27(7):428-33 
49. Boo NY Risk factors associated with feed intolerance in very low 
birthweight infants following initiation of enteral feeds during the 
first 72 hours of life. J Trop Pediatr. 2000 Oct;46(5):272-7. 
 
  
61 
 
ANNEXURE I 
STUDY   PROFORMA 
Name: B/O    Gender: M/F IP No :     
Address:       Study  No :  
Hospital : ICH / IOG 
 
Phone No: 
                                                                                                                                                                                                                                            
Date of birth :    Gestational age :----Weeks----days 
Date of admission :   Date of recruitment :  
Birth weight : ---------grams  Growth Status : SGA/AGA/LGA 
Mode of delivery : Labor  Natural /Instrumental /LSCS      APGAR : 
Resuscitation details : 
                                          Maternal details 
Name :     Age :  Gravid status : 
LMP :      EDD : 
Antenatal steroid : Full course/ Partial course/ No steroids 
Abnormal fetal doppler : Yes/No  Anemia : Yes/No 
62 
 
PIH/ Preeclampsia : Yes/No   Diabetes : Yes/No  
Placenta abruption : Yes/No   Placenta previa : Yes/No       
PROM : ---------hours    Maternal fever : Yes/No       
Foul smelling liquor : Yes/No       
No of PV exam : 
Dysuria : Yes/No  Meconium Stained Amniotic fluid : Yes/No 
Day of life Full enteral feeding group  
 
 
        Standard feeding 
group 
 
Milk(ml/kg) IVF(ml/kg) 
 
Milk(ml/kg) IVF(ml/kg) 
 
Day 1(0-
24hrs) 
    
Day 2(24-
48hrs) 
    
Day 3(48-
72hrs) 
    
Day 4(72-
96hrs) 
    
Day 5(96-
120hrs) 
    
Day 6(120 -
144hrs) 
    
Day 7 +(144 
hours 
onwards) 
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DAY OF LIFE           
WEIGHT(GMS)           
ENTERAL FEEDS           
TOTAL FLUID VOLUME  
ml/kg/day 
          
MOTHER’SMILK           
DONOR MILK           
 IVF  ml/kg/day           
MEASURES OF FEED 
INTOLERANCE 
GASTRIC ASPIRATE >50% 
(Y/N) 
APNOEA,BRADYCARDIA,RESP 
SIGNS(Y/N) 
TEMPARATURE INSTABILITY 
(Y/N) 
ABDOMINAL 
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DISTENSION(Y/N) 
ABDOMINAL 
TENDERNESS(Y/N) 
BRIGHT RED 
BLOOD/RECTUM(Y/N) 
ABSENT BOWEL 
SOUNDS(Y/N) 
VOMITING(Y/N) 
FEEDS OMITTED(Y/N)           
FEEDS REDUCED/NOT 
INCREASED(Y/N) 
          
STOOLS PASSED(Y/N)           
ABDOMINAL RADIOLOGY 
NORMAL XRAY(Y/N) 
INTESTINAL  
DILATATION(Y/N) 
PEUMATOSIS 
INTESTINALIS/PORTAL 
VENOUS GAS 
PNUMOPERITONEUM(Y/N) 
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ANNEXURE II 
PATIENT INFORMATION SHEET  
Postnatal growth failure is a problem in very-low-birth weight 
infants. This subnormal growth often persists into early childhood. Early 
nutrition and neuro developmental outcome are linked. Breast milk is the 
standard of care for VLBW infants. we can  improve outcomes by 
preventing "nutritional insults" during the a critical period between birth 
and when birth weight is regained when optimal nutrition has its greatest 
benefit.  
 Hence we are conducting a study  by using pasteurised, caloric 
human milk  and time taken  to regain birth weight  in very  low birth 
weight infants admitted in our newborn unit . 
After obtaining your consent your baby will be included  in our 
trial. In this study one group of babies will be initiated on full enteral 
feeds on Day 1 with pasteurized human  milk from the Breast Milk Bank 
in our institute. The babies in the other group will be fed as per the unit 
protocol. Your baby will be enrolled in either of the two groups 
randomly. 
The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared.   
  Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
  
Signature of the investigator                               signature of the parent 
 
Date ; 
Place : Chennai 
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ANNEXURE III 
CONSENT FORM 
 I Ms/Mr.___________________________________ M/O//F/O, 
B/O __________________________Sex_____________ 
Hosp. No.________________ admitted in the Neonatal unit was 
explained by the doctor that my baby is a very low birth weight baby at 
birth and  I understood the nutritional needs of my baby. I am willing to 
participate in this trial and I gave my consent to use  pasteurised donor 
human milk to my baby. The adverse effect like feed intolerance were 
explained to me.  
The doctors have explained to me the nature and the purpose of 
the trial. I have given my consent only after completely understanding 
the details that were explained to me. I understand that my baby’s 
routine clinical management is not affected by my participation in this 
trial. 
  I have given this consent to be enrolled in this study with my full 
consciousness. I am willing for my baby to be enrolled in this study 
without any ones compulsion and I am fully aware that I can withdraw 
from the trial at any time during the study. 
 
 
Signature of Investigator                    Signature of the parent                                                                    
Date; 
 Chennai -8. 
68 
 
 
 
 
1 
 
S.
N
o 
R
.N
o 
Fe
ed
in
g 
Ty
pe
 
N
am
e 
Se
x 
IN
ST
 
A
PG
A
R
 
G
A
 
B
W
 
G
ro
w
th
 
A
ne
m
ia
 
M
O
D
 
H
yp
er
te
ns
io
n 
G
D
M
 
A
N
S 
In
fe
ct
io
n 
A
bn
 D
op
pl
er
 
O
lig
oh
yd
ra
m
in
os
 
Fe
ed
 In
to
le
ra
nc
e 
H
yp
og
ly
ce
m
ia
 
C
om
or
bi
d 
Se
ps
is
 
C
PA
P 
V
en
til
at
io
n 
IV
F 
da
ys
 
N
o.
 o
f d
ay
s 
 to
 su
ck
 fe
ed
s 
D
ay
s 
ta
ke
n 
to
 
 r
eg
ai
n 
B
ir
th
 
W
ei
gh
t 
du
ra
tio
n 
of
 h
os
pi
ta
l 
st
ay
 
H
C
 o
n 
ad
m
is
si
on
 
R
at
e 
of
 in
cr
ea
se
 
H
C
/W
k 
L
en
gt
h 
on
 
A
dm
is
si
on
 
N
E
C
 
D
ea
th
 
1 A 25 1 B/o Noorjahan 1 1 3 3 31 
106
0 2 2 2 2 2 1 1 2 2 2 2 3 1 2 1 0 13 17 23 26 
0.6
5 40 2 2 
4  A 10 1 B/o Dhanalakshmi 2 2 3 3 30 
116
0 2 2 2 2 2 3 6 2 2 1 1 1 2 3 3 17 24 23 33 
25.
5 
0.3
5 39 2 2 
3  A 12 2 B/o Lakshmi 2 1 3 3 32 
110
0 2 1 1 2 2 3 1 2 2 1 2 1 2 1 1 21 29 28 42 25 
0.4
5 37 2 2 
19  A 11 1 B/o Ramesa 2 2 3 3 31 
119
0 2 1 1 2 2 3 2 2 2 2 1 1 3 2 3 6 0 0 6 26 0 37 2 1 
5  A 19 2 B/o Meharaj 1 2 3 3 29 
105
0 2 2 2 1 2 3 1 2 2 2 1 3 2 2 2 8 16 23 35 
23.
5 0.4 36 2 2 
9  A 21 1 B/o Parameshwari 2 1 3 3 32 
105
0 2 2 2 1 2 3 1 2 2 2 2 3 1 1 1 0 8 10 11 
26.
5 
0.6
5 37 2 2 
7 
  A 
23 2 B/o Anusiya 2 1 3 3 28 
100
0 2 2 1 2 2 3 1 2 2 2 2 2 2 1 1 6 19 17 31 
24.
5 
0.3
5 37 2 2 
10  A 3 1 B/o Maliga 2 2 2 3 28 
120
0 2 2 1 2 2 1 6 2 2 1 2 7 2 3 1 14 22 20 27 
24.
5 
0.4
5 36 2 2 
6  A 5 1 B/o Kaliyammal 2 2 3 3 31 
103
0 1 1 1 2 2 2 1 2 1 2 2 1 2 3 1 6 18 16 23 26 0.5 37 2 2 
8  A 8 1 B/o Karpagam 1 2 2 3 28 
103
0 2 1 1 1 2 3 1 2 2 1 1 2 3 3 4 20 0 0 21 
23.
5 0 35 2 1 
24 1 B 1 B/o Geetha 1 2 3 3 30 
135
0 2 1 1 1 2 3 1 2 2 1 2 3 1 2 1 1 10 15 19 28 0.5 40 2 2 
12 A 4 2 B/o Gunasundari 2 1 3 3 28 
110
0 2 2 2 1 2 3 1 2 1 1 1 8 3 2 3 20 0 0 20 
23.
5 0.3 34 2 1 
59 11 B 1 B/o Geetha 1 1 3 3 30 
135
0 2 2 1 1 2 3 6 2 2 2 2 3 1 2 1 2 14 16 21 
25.
5 
0.3
5 41 2 2 
14 A 13 2 
B/o 
Thiruparasundari 1 2 3 3 33 
100
0 1 1 2 2 2 2 6 2 1 1 2 1 1 1 1 13 18 19 27 25 0.5 37 2 2 
15 A 9 2 B/o Sandhiya 1 2 3 3 29 
112
0 2 2 1 2 2 3 6 2 2 1 1 2 1 1 1 6 17 19 28 27 0.5 38 2 2 
16  A 28 2 B/o Mumtaj 1 2 3 3 31 
115
5 2 2 1 2 2 3 6 2 2 1 2 9 2 1 2 4 0 0 4 
26.
5 0.2 37 2 1 
17 A 18 2 B/o Lalitha 2 1 3 3 31 
117
0 2 2 1 1 2 1 2 2 2 2 2 2 1 1 1 5 16 18 26 28 
0.5
5 38 2 2 
18 A 2 2 B/o Rekha 1 2 2 3 32 
115
0 1 1 2 1 2 1 1 2 2 2 2 2 1 1 1 4 10 15 25 26 0.4 37 2 2 
63 17 B 1 B/o Anitha 1 1 3 3 31 
125
0 2 2 1 1 2 1 1 2 2 2 2 1 1 1 1 0 15 18 22 
25.
5 
0.4
5 42 2 2 
20 20 B 2 B/o Divya Bharathi 1 2 3 3 32 
145
0 2 2 2 1 2 3 1 2 2 1 2 1 2 3 1 10 14 15 19 27 0.6 39 2 2 
66 18 B 1 B/o Mouli 1 2 3 3 33 
144
0 1 2 2 1 2 1 1 2 2 2 1 3 1 3 1 8 15 14 16 26 0.5 40 2 2 
22 46B 2 B/o Sheerin-I 1 2 3 3 30 
134
0 2 1 1 1 2 3 1 2 2 2 1 7 2 3 4 13 20 22 24 28 
0.3
5 42 2 2 
2 
 
46 2 B 1 B/o Sridevi 2 2 3 3 32 
139
0 2 2 2 1 2 3 1 2 2 2 2 1 1 2 1 0 13 15 21 
25.
5 
0.3
5 38 2 2 
43 21 B 1 B/o Sarala 2 2 3 3 33 
149
0 2 1 1 1 2 3 1 2 2 2 2 1 1 1 1 0 6 13 17 
27.
5 0.4 38 2 2 
25 4 B 2 B/o Mangaiyakarasi 1 2 3 3 33 
145
0 2 2 2 2 2 1 1 2 2 2 1 7 3 2 3 14 16 21 23 27 0.4 43 2 2 
26 27 B 1 B/o Karpagam-I 1 2 3 3 31 
132
0 2 1 2 2 2 2 1 2 2 2 2 3 1 1 1 0 12 16 23 
27.
5 
0.3
5 40 2 2 
27 56 B 2 B/o Karpagam-II 2 2 3 3 31 
150
0 2 2 2 2 2 2 1 2 2 2 1 1 2 2 2 6 10 16 23 29 
0.4
5 43 2 2 
44 32 B 1 B/o Dhanalakshmi 1 2 3 3 31 
140
0 2 2 1 1 1 3 1 2 2 2 2 1 1 1 1 2 13 15 18 28 
0.5
5 42 2 2 
29 30 B 2 B/o Iswariya 1 2 3 3 35 
148
0 1 1 1 2 2 3 1 2 2 2 2 1 1 2 1 4 7 11 13 29 
0.3
5 41 2 2 
30 5B 2 B/o Kavitha-II 1 2 3 3 32 
140
0 2 1 1 2 2 1 1 2 2 2 2 1 2 2 1 10 12 18 23 
27.
5 
0.3
5 42 2 2 
31 72 B 2 B/o Thenmozhi 2 2 3 3 35 
139
0 5 2 1 1 2 3 1 2 2 2 2 1 1 1 1 4 3 10 12 
30.
5 
0.2
5 43 2 2 
65 33 B 1 B/o Chitra 2 2 3 3 33 
148
5 1 2 2 2 2 3 2 2 2 2 2 2 3 2 2 10 16 15 18 26 0.5 41 2 2 
33 71 B 2 B/o Maibeen 2 2 3 3 34 
142
0 1 1 1 1 2 2 1 2 2 2 1 1 1 1 1 4 6 14 15 
28.
5 
0.4
5 40 2 2 
34 3 B 2 B/o Lakshmi 1 2 3 3 31 
136
0 2 2 1 1 2 2 2 2 2 2 1 1 1 1 1 7 12 13 15 
26.
5 0.4 38 2 2 
37 37 B 1 B/o Ammu-II(Tri) 2 2 3 3 36 
127
5 5 2 2 1 2 2 1 2 2 2 2 1 1 1 1 0 5 13 17 
27.
5 
0.6
5 39 2 2 
36 50 B 2 B/o Sofiya Mary 1 2 3 3 31 
123
0 2 1 2 1 2 3 1 2 2 2 2 3 1 3 1 8 15 10 17 26 0.5 37 2 2 
40 41 B 1 B/o Subbulakshmi 2 2 3 3 30 
131
5 2 2 1 1 2 3 1 2 2 1 1 3 3 2 3 10 22 16 30 
26.
5 
0.3
5 
38.
5 2 2 
38 24 B 2 B/o Ammu-III(Tri) 2 2 3 3 36 
136
5 1 2 2 2 2 2 1 2 2 2 2 2 1 2 2 5 8 10 17 24 0.5 39 2 2 
39 14 B 2 B/o Geetha 2 1 2 3 31 
129
0 2 1 1 1 2 1 2 1 2 1 2 7 2 3 2 10 15 18 27 26 0.3 36 2 2 
56 44 B 1 B/o Suguna-I 2 2 3 3 33 
147
0 2 2 1 1 2 3 2 2 2 2 2 1 1 1 1 0 5 13 17 26 0.4 36 2 2 
28 47 B 1 B/o Tulasi 1 2 3 3 32 
142
0 2 2 1 2 2 2 1 2 2 2 2 1 1 1 1 0 6 14 16 29 0.7 40 2 2 
42 10 B 2 B/o Kavitha 1 2 3 3 32 
135
0 2 2 2 2 2 3 1 1 2 2 2 3 1 3 1 7 13 13 15 
26.
5 
0.2
5 38 2 2 
62 48 B 1 B/o Vimala 1 2 3 3 29 
125
0 2 2 1 1 2 1 1 2 2 1 2 8 3 2 3 15 16 15 19 25 
0.4
5 36 2 2 
57 51 B 1 B/o Maheswari 2 2 3 3 33 
136
5 2 2 2 1 2 1 1 2 2 2 2 1 1 1 1 0 6 9 11 
26.
5 
0.5
5 40 2 2 
45 57 B 1 B/o Mala-I 1 2 3 3 33 
146
0 1 2 1 1 2 1 1 2 2 2 2 1 2 2 1 0 6 17 16 
30.
5 
0.4
5 43 2 2 
32 6 B 1 B/o Usha 2 2 3 3 33 
150
0 2 1 2 2 2 1 1 2 2 2 2 1 1 1 1 0 5 15 18 30 
0.3
5 42 2 2 
47 42 B 2 B/o Anuradha 1 1 3 3 33 
141
0 2 1 2 1 2 3 1 2 2 2 2 1 1 1 1 5 7 10 11 
27.
5 
0.3
5 40 2 2 
48 60 B 2 B/o Shalini-I 2 1 3 3 32 
135
0 2 1 2 2 2 3 6 2 2 1 2 3 2 1 1 9 16 15 18 
28.
5 
0.2
5 40 2 2 
49 34 B 2 B/o Easwari 1 2 3 3 33 142 2 2 1 1 2 3 1 2 2 2 2 3 2 2 1 4 6 10 10 28 0.5 39 2 2 
3 
 
0 
50 68 B 2 B/o Punitha 1 2 3 3 35 
149
5 1 2 1 1 2 1 1 2 2 1 1 1 1 1 1 3 5 9 9 26 0.5 40 2 2 
51 45 B 2 B/o Shalini-II 1 2 3 3 35 
145
0 2 2 1 1 2 1 1 2 2 1 2 1 2 1 1 6 12 14 18 30 
0.4
5 41 2 2 
52 38 B 2 B/o Benitha 2 1 3 3 30 
126
0 2 2 1 1 1 1 1 2 2 1 2 1 3 1 1 8 16 18 23 26 0.4 35 2 2 
53 64 B 2 B/o Suguna-II 2 2 3 3 34 
145
0 2 2 1 1 2 3 1 2 2 2 2 1 2 1 1 3 4 15 17 27 0.6 41 2 2 
54 28 B 2 B/o Nishanthini 1 1 3 3 35 
150
0 1 1 1 1 2 1 6 2 2 1 2 1 1 1 1 4 3 8 13 
27.
5 0.7 37 2 2 
21 61 B 1 B/o Asha 1 2 3 3 33 
142
0 2 1 1 1 2 3 1 2 2 2 2 1 1 1 1 0 5 14 16 29 0.4 40 2 2 
41 65 B 1 B/o Venda 1 2 3 3 33 
140
0 2 2 1 2 2 2 1 2 2 2 2 1 1 1 1 0 8 14 16 30 
0.4
5 42 2 2 
35 69 B 1 B/o Grace 1 2 3 3 31 
135
0 2 1 2 1 2 3 1 2 2 2 2 3 2 3 1 3 12 12 14 
25.
5 0.5 
37.
5 2 2 
60 7 B 1 B/o Indhumathi 2 1 3 3 34 
128
5 1 2 1 1 2 1 6 2 1 1 1 1 3 2 3 22 0 15 24 
25.
5 
0.3
5 38 2 1 
55 70 B 1 B/o Vanisri 2 1 3 3 30 
135
0 2 1 1 2 2 2 1 2 2 1 2 3 1 3 1 2 15 13 18 26 0.4 37 2 2 
58 73 B 1 B/o Rekha 1 2 3 3 31 
125
0 2 2 1 1 2 1 1 2 1 2 2 1 2 2 1 1 15 10 20 27 0.5 41 2 2 
61 12 B 2 
B/o Sangmayadhav-
II 2 1 3 3 30 
126
5 2 2 2 1 2 1 1 2 2 1 2 3 2 1 3 23 0 19 23 27 0.3 40 2 1 
23 80 B 1 B/o Sheerin-II 1 2 3 3 30 
143
0 2 1 1 1 2 3 1 2 2 1 1 2 2 3 3 15 22 18 24 
27.
5 
0.4
5 42 2 2 
2 A 1 1 B/o Shanthi 2 1 3 3 30 
110
0 2 2 1 1 2 1 1 2 2 2 1 2 1 2 1 2 15 11 17 
24.
5 0.7 36 2 2 
64 78 B 2 B/o Nallini 2 2 3 3 30 
130
0 2 2 1 1 2 3 6 2 2 2 2 3 1 2 1 8 13 15 21 
25.
5 
0.2
5 39 2 2 
13 A 26 1 B/o Lalitha 1 1 2 3 28 
102
5 2 2 1 2 2 3 1 2 2 1 1 3 2 2 2 16 28 23 43 
25.
5 0.6 35 2 2 
11 A 6 1 B/o Maheswari 1 2 3 3 33 
102
0 5 1 2 1 2 2 6 2 2 2 2 1 2 3 3 21 0 19 21 
26.
5 0.2 38 2 1 
67 63 B 2 B/o Amudha 2 1 3 3 33 
138
0 2 2 2 2 2 3 6 2 2 2 2 1 1 2 1 6 7 10 10 26 
0.2
5 37 2 2 
68 49 B 2 B/o Kalaiarasi 1 2 3 3 32 
144
0 2 2 1 2 2 1 1 2 2 2 2 3 2 2 1 6 12 14 15 
26.
5 0.4 36 2 2 
69 B 76 2 B/o Janani 1 2 3 3 31 
120
0 2 1 2 1 2 1 1 2 2 2 2 2 1 2 1 8 12 17 28 
27.
5 0.4 38 2 2 
 
